The demand for immunoprotein diagnostic testing is continuously increasing with advancements in technology and development of innovative products, expanding the scope of market. Innovations and new developments have resulted in the widening of the application areas of immunoprotein diagnostic testing such as allergy testing, oncology, infectious disease testing, and drug abuse testing. Of late, the intense research and development activities in the field of oncology have resulted in the discovery of several biomarkers, which are encouraging the growth of the market. These biomarkers have been profiled to treat specific type so cancer, which is boosting the market.
Demand for ELISA Boosts Immunoprotein Diagnostic Testing Market
Techniques such as ELISA, immunofluorescence, chemiluminescence, and others have become a powerful tool for disease diagnosis. Currently radioimmunoassay finds application only in hormone testing and cancer testing, where higher level of accuracy is needed. However, the application area is expected to widen with increased research and development activities. The demand for multiplex ELISA is also growing owing to its advantage of testing a sample for multiple biomarkers in a single assay cycle. The demand for multiplex ELISA is expected to outgrow other techniques in cancer diagnosis as it requires less amount of sample.
Emerging Nations to Create Opportunities of Growth in Immunoprotein Diagnostic Testing Market
The higher prevalence of malaria, dengue, typhoid, tuberculosis, and cancer in emerging economies is acting as an opportunity in the immunoprotein diagnostic testing market. Additionally, the population of countries in South East Asia is high, which is beneficial for the market. Cost effective diagnostic kits for infectious diseases are greatly in demand in these regions. As such, the immunoprotein diagnostic testing market is expected to witness a heightened growth owing to ample opportunities offered by the emerging economies of Asia Pacific.